After falling behind 76-49 at halftime of Game 4 of the NBA Finals, it would make sense for fans to chalk up another L for the New York Knicks against the San Antonio Spurs. Mitch Johnson’s squad was ...

If the ratings have been phenomenal for the NBA Finals so far, the numbers for this Game 4 might defy superlatives. Or maybe, to take a cue from ABC play-by-play announcer Mike Breen, they might just ...

This will live in those special places not just in Knicks lore, not just in NBA lore, but in sports lore. This is one of the great comebacks — 29 points, most in NBA Finals history — in sports history ...

The National Science Foundation has been roiled by changes since President Trump took office for his second term. The administration canceled a slew of grants, cut its staff, ordered “senior ...

CNBC's Diana Olick reports on news regarding the housing market. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this ...

President Donald Trump on Saturday floated the idea of hosting a massive MAGA rally to commemorate the nation’s 250th anniversary after numerous artists pulled out of a planned concert this summer. In ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The university reached the ...

Earlier this week, Congressman Mike Thompson was honored by the Sutter County Board of Supervisors for his quick efforts to deliver $9 million in federal funding for a peach tree pull program after ...

Anderson Cooper signed off of “60 Minutes” on Sunday with a salute to the newsmagazine’s editorial independence and longevity. He told viewers “I hope ’60 Minutes’ remains ’60 Minutes’ ” in a segment ...

May 6 (Reuters) - Sanofi (SASY.PA), opens new tab has asked the U.S. Food and Drug Administration to pull its diabetes drug out of the regulator's new fast-track review program, STAT News reported on ...

May 6 (Reuters) - Sanofi has asked the U.S. Food and Drug Administration to pull its diabetes drug out of the regulator's new ‌fast-track review program, STAT News reported on Wednesday. The move ...